Vanguard Group Inc. Has $133.14 Million Position in Trupanion, Inc. $TRUP

Key Points

• Vanguard Group Inc. has reduced its stake in Trupanion, Inc. by 0.7%, now holding 3,572,305 shares valued at approximately $133 million, following the sale of 24,420 shares in the first quarter.
• Trupanion reported $0.22 earnings per share for the last quarter, exceeding analysts' expectations, and its revenue increased by 12.3% compared to the same quarter last year.
• Several hedge funds, including Balyasny Asset Management and Northern Trust Corp., have significantly increased their holdings in Trupanion, with Balyasny raising its stake by 368.2% last quarter.

Vanguard Group Inc. lessened its holdings in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 0.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,572,305 shares of the financial services provider's stock after selling 24,420 shares during the period. Vanguard Group Inc. owned about 8.35% of Trupanion worth $133,140,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Quarry LP acquired a new position in Trupanion during the fourth quarter valued at $39,000. Coppell Advisory Solutions LLC increased its holdings in shares of Trupanion by 58.3% in the 4th quarter. Coppell Advisory Solutions LLC now owns 1,249 shares of the financial services provider's stock valued at $61,000 after purchasing an additional 460 shares during the period. PNC Financial Services Group Inc. lifted its position in shares of Trupanion by 11.8% in the first quarter. PNC Financial Services Group Inc. now owns 2,234 shares of the financial services provider's stock worth $83,000 after purchasing an additional 235 shares in the last quarter. Bayesian Capital Management LP purchased a new stake in shares of Trupanion in the fourth quarter worth approximately $201,000. Finally, Eschler Asset Management LLP acquired a new stake in shares of Trupanion during the fourth quarter worth approximately $214,000.

Insiders Place Their Bets

In other news, CFO Fawwad Qureshi sold 2,534 shares of the company's stock in a transaction dated Thursday, May 29th. The shares were sold at an average price of $48.31, for a total transaction of $122,417.54. Following the completion of the transaction, the chief financial officer owned 3,545 shares of the company's stock, valued at approximately $171,258.95. This represents a 41.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO John R. Gallagher sold 4,000 shares of the stock in a transaction dated Thursday, May 29th. The shares were sold at an average price of $47.90, for a total transaction of $191,600.00. Following the completion of the sale, the chief operating officer owned 26,966 shares of the company's stock, valued at approximately $1,291,671.40. The trade was a 12.92% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 7,562 shares of company stock worth $361,430 in the last ninety days. 5.42% of the stock is currently owned by insiders.

Trupanion Stock Performance

Trupanion stock traded down $1.10 on Friday, reaching $46.63. 483,502 shares of the stock were exchanged, compared to its average volume of 558,249. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.32. The firm has a fifty day moving average price of $50.91 and a two-hundred day moving average price of $44.04. The stock has a market cap of $2.00 billion, a PE ratio of 179.35 and a beta of 1.78. Trupanion, Inc. has a twelve month low of $31.00 and a twelve month high of $57.90.

Trupanion (NASDAQ:TRUP - Get Free Report) last announced its earnings results on Thursday, August 7th. The financial services provider reported $0.22 earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.25. Trupanion had a return on equity of 3.31% and a net margin of 0.81%.The firm had revenue of $353.56 million during the quarter, compared to the consensus estimate of $346.73 million. During the same quarter in the prior year, the company earned ($0.14) EPS. The firm's revenue for the quarter was up 12.3% compared to the same quarter last year. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Sell-side analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current year.

Wall Street Analyst Weigh In

TRUP has been the topic of several research analyst reports. Stifel Nicolaus boosted their price target on shares of Trupanion from $41.00 to $45.00 and gave the company a "hold" rating in a report on Friday, August 8th. Piper Sandler lifted their price objective on Trupanion from $62.00 to $67.00 and gave the company an "overweight" rating in a research report on Friday, August 8th. Cantor Fitzgerald upgraded Trupanion to a "hold" rating in a research note on Wednesday, August 13th. Finally, Lake Street Capital cut their price target on Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a research note on Friday, May 2nd. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Trupanion has a consensus rating of "Moderate Buy" and an average price target of $54.17.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.